Amalgamated Financial’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Amalgamated Financial’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2K	Buy	+41	New	+$2.46K	﹤0.01%	2989

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Financial's MDVL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2022: 41 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2989 among its holdings.

49 funds tracked by Wall St. Rank hold MDVL as of Q1 2022.

Amalgamated Financial held 41 shares of MedAvail Holdings, Inc. Common Stock worth $2K as of Q1 2022.
MedAvail Holdings, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
MedAvail Holdings, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2989 holding.
49 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.